Albert Lasker
Clinical Medical Research Award
Cushman, D.W., Plusec, J., Williams, H.J., Weaver, E.R., Sabo, E.F., Kocy, O., Cheung, H.S., and Ondetti, M.A. (1973) Inhibition of angiotensin-converting enzyme by analogs of peptides from Bothrops jacaraca venom. Experientia 29: 10321035.
Ondetti, M.A., Rubin, B., and Cushman, D.W. (1977) Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents. Science 196: 441444.
Cushman, D.W., Cheung, H.S., Sabo, E.F., Ondetti, M.A. (1978) Design of potent competitive inhibitors of angiotensin-converting enzyme, carboxyalkanoyl and mercaptoalkanoyl amino acids. Biochemistry 16: 54845491.
Ondetti, M.A., Condon, M.E., Reid, J., Sabo, E.F. Cheung, H.S., Cushman, D.W. (1979) Design of specific inhibitors of carboxypeptidases. A and B. Biochemistry 18:14271430.
Cheung, H.S., Wang, F.L., Ondetti, M.A., Sabo, E.F., and Cushman, D.W. (1980) Binding of peptide substrates and inhibitors of angiotensins-converting enzyme: importance of the carboxyl-terminal dipeptide sequence. J. Biol. Chem. 225: 410417.
Cushman, D.W. and Ondetti, M.A. History of the design of Captopril and related inhibitors of angiotensin converting enzyme. (1992) Hypertension 17: 589592.